Epkin
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors (NCT06789172) | Epkin | 2025-01-23 |
Track Epkin automatically
Every clearance here is in the API, with alerts when new ones post.